Premarketing observational studies of population pharmacokinetics of new drugs
Related Experiment Videos
Clinical Pharmacology and Therapeutics
|November 1, 1985
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Are all measures of liver Kpuu a function of FH, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2024
An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2018
The Universally Unrecognized Assumption in Predicting Drug Clearance and Organ Extraction Ratio.
Clinical pharmacology and therapeutics·2017
Between-Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial.
Clinical pharmacology and therapeutics·2016
Isoniazid hair concentrations in children with tuberculosis: a proof of concept study.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2016
Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial.
Clinical pharmacology and therapeutics·2016
Evaluating the Association Between PPI Use and Dementia Risk Considering Methodological Choices: An Updated Meta-Analysis.
Clinical pharmacology and therapeutics·2026
Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation.
Clinical pharmacology and therapeutics·2026
Use of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors in Incident Hyponatremia in Patients with Type 2 Diabetes: Multicenter Target Trial Emulations.
Clinical pharmacology and therapeutics·2026
The EMA Qualification Opinion for CYP Inhibition-Mediated Drug-Drug Interaction Predictions: Implications for PBPK Credibility Assessment in the Era of ICH M15.
Clinical pharmacology and therapeutics·2026
Advancing Therapeutics for Children with Medical Complexity: The Role of Model-Informed Precision Dosing and Genotype-Stratified Trials.
Clinical pharmacology and therapeutics·2026
Quantitative Sciences in the Model-Informed Era: From Parallel Functions to a Shared Decision System.
Clinical pharmacology and therapeutics·2026
Dual targeting of DHODH and SLC29A1 overcomes metabolic resistance and enhances antitumor immune responses in PDAC.
Molecular cancer therapeutics·2026
Obesity Medications in Older Adults: A Geriatrics 5Ms Framework for Safe and Patient-Centered Prescribing.
Journal of the American Geriatrics Society·2026
Antipsychotic Prescriptions for Prenatal and Postpartum Women in Japan: A Large Claims Database Study.
Pharmacology research & perspectives·2026